69 results
Page 2 of 4
8-K
EX-99.1
4ubcglmnfh1wgy
5 May 22
Maravai Lifesciences Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
55v0e
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
8-K
EX-10.1
l7i8r3im2tjry
20 Jan 22
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
4p88giyr2 ns
3 Sep 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-2.1
pxz5pys
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
zc32kot
12 May 21
Quarterly report
4:26pm
10-K
14q3e4q6n5ie
22 Mar 21
Annual report
4:22pm
8-K
EX-1.1
uhn65luupi5py2zuc14v
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.8
pfu1b
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.10
7seht
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.9
a03i5a4s
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
3dj h1obrr
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1/A
EX-1.1
2g734m9u4o6od5w
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.26
sttmvdu
9 Nov 20
IPO registration (amended)
2:05pm